Skip to main content

Development of liposomal gemcitabine with high drug loading capacity

Research Abstract
Liposomes are widely used for systemic delivery of chemotherapeutic agents to reduce their nonspecific side effects. Gemcitabine (Gem) makes a great candidate for liposomal encapsulation due to the short half-life and non-specific side effects; however, it has been difficult to achieve liposomal Gem with high drug loading capacity. Remote loading, which uses a transmembrane pH gradient to induce influx of drug and locks the drug in the core as a sulfate complex, does not serve Gem as efficiently as doxorubicin (Dox) due to the low pKa value of Gem. Existing studies have attempted to improve Gem loading capacity in liposomes by employing lipophilic Gem derivatives or creating a high concentration gradient for active loading into the hydrophilic cores (small volume loading). In this study we combine remote loading approach and small volume loading or hypertonic loading, a new approach to induce the influx of Gem into the preformed liposomes by high osmotic pressure, to achieve a Gem loading capacity of 9.4 – 10.3 wt% in contrast to 0.14 – 3.8 wt% of the conventional methods. Liposomal Gem showed a good stability during storage, sustained-release over 120 h in vitro, enhanced cellular uptake and improved cytotoxicity as compared to free Gem. Liposomal Gem showed a synergistic effect with liposomal Dox on Huh7 hepatocellular carcinoma cells. A mixture of liposomal Gem and liposomal Dox delivered both drugs to the tumor more efficiently than a free drug mixture and showed a relatively good anti-tumor effect in a xenograft model of hepatocellular carcinoma. This study shows that bioactive liposomal Gem with high drug loading capacity can be produced by remote loading combined with additional approaches to increase drug influx into the liposomes.
Research Authors
Tamam Hassan, Park Jinho, Gadalla Hytham H., Andrea R. Masters, Jelan A. Abdel-Aleem, Sayed I. Abdelrahman, Aly A. Abdelrahman, L. Tiffany Lyle, Yoon Yeo
Research Department
Research Journal
Mol Pharm
Research Publisher
HHS Public Access
Research Rank
1
Research Vol
16(7)
Research Website
PMC 2020 January 01.
Research Year
2019

Development of liposomal gemcitabine with high drug loading capacity

Research Abstract
Liposomes are widely used for systemic delivery of chemotherapeutic agents to reduce their nonspecific side effects. Gemcitabine (Gem) makes a great candidate for liposomal encapsulation due to the short half-life and non-specific side effects; however, it has been difficult to achieve liposomal Gem with high drug loading capacity. Remote loading, which uses a transmembrane pH gradient to induce influx of drug and locks the drug in the core as a sulfate complex, does not serve Gem as efficiently as doxorubicin (Dox) due to the low pKa value of Gem. Existing studies have attempted to improve Gem loading capacity in liposomes by employing lipophilic Gem derivatives or creating a high concentration gradient for active loading into the hydrophilic cores (small volume loading). In this study we combine remote loading approach and small volume loading or hypertonic loading, a new approach to induce the influx of Gem into the preformed liposomes by high osmotic pressure, to achieve a Gem loading capacity of 9.4 – 10.3 wt% in contrast to 0.14 – 3.8 wt% of the conventional methods. Liposomal Gem showed a good stability during storage, sustained-release over 120 h in vitro, enhanced cellular uptake and improved cytotoxicity as compared to free Gem. Liposomal Gem showed a synergistic effect with liposomal Dox on Huh7 hepatocellular carcinoma cells. A mixture of liposomal Gem and liposomal Dox delivered both drugs to the tumor more efficiently than a free drug mixture and showed a relatively good anti-tumor effect in a xenograft model of hepatocellular carcinoma. This study shows that bioactive liposomal Gem with high drug loading capacity can be produced by remote loading combined with additional approaches to increase drug influx into the liposomes.
Research Authors
Tamam Hassan, Park Jinho, Gadalla Hytham H., Andrea R. Masters, Jelan A. Abdel-Aleem, Sayed I. Abdelrahman, Aly A. Abdelrahman, L. Tiffany Lyle, Yoon Yeo
Research Department
Research Journal
Mol Pharm
Research Member
Research Publisher
HHS Public Access
Research Rank
1
Research Vol
16(7)
Research Website
PMC 2020 January 01.
Research Year
2019

Formulation and Evaluation of verapamil Hcl buccoadhesive tablets and films, Unique Journal of pharmaceutical and biological sciences,01(03),48-57,2013.

Research Abstract
Verapamil hydrochloride (Vp-HCl) is a calcium channel blocker and class IV antiarrythmic drug. Its oral bioavailability is about 20- 30% because of the extensive first-pass metabolism, so it is advisable to prepare the drug in a buccoadhesive dosage forms to bypass first-pass metabolism and thus achieving constant plasma concentrations during treatment of chronic hypertension. Certain bioadhesive polymers were used either singly or in combinations at different ratios in order to select the best matrix forming tablets with satisfactory drug release, characteristic bioadhesiveness and swelling properties. It was found that the drug release decreased by increasing the concentration of the polymer in all the studied formulations and the drug release from using polymer blends is slower than those containing single polymer. Tablet formula containing either 30% (w/w) hydroxypropyl methyl cellulose 15000(HPMC 15000) & 10% (w/w) sodium carboxymethyl cellulose (SCMC), or containing 5% (w/w) carbopol 934P (Cp934P) with either 15% (w/w) HPMC 15000 or 30% (w/w) sodium alginate (NaAlg) was developed to a satisfactory level in terms of drug release, bioadhesive performance and swelling properties. Plasma concentration time curves obtained following buccal administration of the optimal prepared buccoadhesive tablets to rabbits showed evidence of sustained release of Vp-HCl. Bioavailability of Vp-HCl formulated tablets formulae (T31, T35 & T38) was approximately two times higher than that achieved after oral administration of commercial tablets.
Research Authors
Ahmad Aboutaleb.Aly Abdel Zaher Abdel Rahma,Eman Mostafa Samy and Marwa Glal
Research Department
Research Journal
Unique Journal of pharmaceutical and biological sciences
Research Publisher
NULL
Research Rank
1
Research Vol
01 (03)
Research Website
www.ujconline.net
Research Year
2013

Formulation and Evaluation of verapamil Hcl buccoadhesive tablets and films, Unique Journal of pharmaceutical and biological sciences,01(03),48-57,2013.

Research Abstract
Verapamil hydrochloride (Vp-HCl) is a calcium channel blocker and class IV antiarrythmic drug. Its oral bioavailability is about 20- 30% because of the extensive first-pass metabolism, so it is advisable to prepare the drug in a buccoadhesive dosage forms to bypass first-pass metabolism and thus achieving constant plasma concentrations during treatment of chronic hypertension. Certain bioadhesive polymers were used either singly or in combinations at different ratios in order to select the best matrix forming tablets with satisfactory drug release, characteristic bioadhesiveness and swelling properties. It was found that the drug release decreased by increasing the concentration of the polymer in all the studied formulations and the drug release from using polymer blends is slower than those containing single polymer. Tablet formula containing either 30% (w/w) hydroxypropyl methyl cellulose 15000(HPMC 15000) & 10% (w/w) sodium carboxymethyl cellulose (SCMC), or containing 5% (w/w) carbopol 934P (Cp934P) with either 15% (w/w) HPMC 15000 or 30% (w/w) sodium alginate (NaAlg) was developed to a satisfactory level in terms of drug release, bioadhesive performance and swelling properties. Plasma concentration time curves obtained following buccal administration of the optimal prepared buccoadhesive tablets to rabbits showed evidence of sustained release of Vp-HCl. Bioavailability of Vp-HCl formulated tablets formulae (T31, T35 & T38) was approximately two times higher than that achieved after oral administration of commercial tablets.
Research Authors
Ahmad Aboutaleb.Aly Abdel Zaher Abdel Rahma,Eman Mostafa Samy and Marwa Glal
Research Department
Research Journal
Unique Journal of pharmaceutical and biological sciences
Research Publisher
NULL
Research Rank
1
Research Vol
01 (03)
Research Website
www.ujconline.net
Research Year
2013

Formulation and Evaluation of verapamil Hcl buccoadhesive tablets and films, Unique Journal of pharmaceutical and biological sciences,01(03),48-57,2013.

Research Abstract
Verapamil hydrochloride (Vp-HCl) is a calcium channel blocker and class IV antiarrythmic drug. Its oral bioavailability is about 20- 30% because of the extensive first-pass metabolism, so it is advisable to prepare the drug in a buccoadhesive dosage forms to bypass first-pass metabolism and thus achieving constant plasma concentrations during treatment of chronic hypertension. Certain bioadhesive polymers were used either singly or in combinations at different ratios in order to select the best matrix forming tablets with satisfactory drug release, characteristic bioadhesiveness and swelling properties. It was found that the drug release decreased by increasing the concentration of the polymer in all the studied formulations and the drug release from using polymer blends is slower than those containing single polymer. Tablet formula containing either 30% (w/w) hydroxypropyl methyl cellulose 15000(HPMC 15000) & 10% (w/w) sodium carboxymethyl cellulose (SCMC), or containing 5% (w/w) carbopol 934P (Cp934P) with either 15% (w/w) HPMC 15000 or 30% (w/w) sodium alginate (NaAlg) was developed to a satisfactory level in terms of drug release, bioadhesive performance and swelling properties. Plasma concentration time curves obtained following buccal administration of the optimal prepared buccoadhesive tablets to rabbits showed evidence of sustained release of Vp-HCl. Bioavailability of Vp-HCl formulated tablets formulae (T31, T35 & T38) was approximately two times higher than that achieved after oral administration of commercial tablets.
Research Authors
Ahmad Aboutaleb.Aly Abdel Zaher Abdel Rahma,Eman Mostafa Samy and Marwa Glal
Research Department
Research Journal
Unique Journal of pharmaceutical and biological sciences
Research Publisher
NULL
Research Rank
1
Research Vol
01 (03)
Research Website
www.ujconline.net
Research Year
2013

Formulation and Evaluation of verapamil Hcl buccoadhesive tablets and films, Unique Journal of pharmaceutical and biological sciences,01(03),48-57,2013.

Research Abstract
Verapamil hydrochloride (Vp-HCl) is a calcium channel blocker and class IV antiarrythmic drug. Its oral bioavailability is about 20- 30% because of the extensive first-pass metabolism, so it is advisable to prepare the drug in a buccoadhesive dosage forms to bypass first-pass metabolism and thus achieving constant plasma concentrations during treatment of chronic hypertension. Certain bioadhesive polymers were used either singly or in combinations at different ratios in order to select the best matrix forming tablets with satisfactory drug release, characteristic bioadhesiveness and swelling properties. It was found that the drug release decreased by increasing the concentration of the polymer in all the studied formulations and the drug release from using polymer blends is slower than those containing single polymer. Tablet formula containing either 30% (w/w) hydroxypropyl methyl cellulose 15000(HPMC 15000) & 10% (w/w) sodium carboxymethyl cellulose (SCMC), or containing 5% (w/w) carbopol 934P (Cp934P) with either 15% (w/w) HPMC 15000 or 30% (w/w) sodium alginate (NaAlg) was developed to a satisfactory level in terms of drug release, bioadhesive performance and swelling properties. Plasma concentration time curves obtained following buccal administration of the optimal prepared buccoadhesive tablets to rabbits showed evidence of sustained release of Vp-HCl. Bioavailability of Vp-HCl formulated tablets formulae (T31, T35 & T38) was approximately two times higher than that achieved after oral administration of commercial tablets.
Research Authors
Ahmad Aboutaleb.Aly Abdel Zaher Abdel Rahma,Eman Mostafa Samy and Marwa Glal
Research Department
Research Journal
Unique Journal of pharmaceutical and biological sciences
Research Publisher
NULL
Research Rank
1
Research Vol
01 (03)
Research Website
www.ujconline.net
Research Year
2013

ENCAPSULATION OF ANTENNAPEDIA (PENETRATIN) PEPTIDE IN A POLYMERIC PLATFORM FOR EFFECTIVE TREATMENT OF
INTRACELLULAR BACTERIA

Research Abstract
Antimicrobial peptides (AMP) and cell-penetrating peptides (CPP) are two classes of peptides that share some structural and physicochemical similarities. Antennapedia or penetratin (ANT) is one of the most known CPPs, that was proven to have antimicrobial activity against certain strains of planktonic bacteria. ANT can enter the cells but has no activity against intracellular bacteria. This is attributable to the inability of the peptide to reach bacteria reside within cellular components as well as low delivery efficiency, due to loss of activity by proteolysis and poor specificity. The aim of this work is to develop a formulation that can effectively reach and attack intracellular bacteria. To achieve this goal, ANT was encapsulated in PLGA platform as nanoparticles with the size range of 500-1000 nm, which allows for selective uptake by macrophages where bacteria mostly reside. ANT was loaded with high loading efficiency (12.7%) inspite of high water solubility. ANT-nanoparticles (ANT-NP) had no cytotoxicity on J774a.1 macrophages and were readily taken up by macrophages as confirmed by fluorescence microscopy. Antibacterial activity of ANT-NP remains to be tested against different intracellular bacteria.
Research Authors
Marwa G. Elnaggar, Hesham M. Tawfeek, Aly A. Abdel-Rahman, Ahmed E. Aboutaleb and Yoon Yeo
Research Department
Research Journal
Bull. Pharm. Sci., Assiut University
Research Publisher
Faculty of Pharmacy, Assiut University
Research Rank
1
Research Vol
Vol. 42
Research Website
http://www.aun.edu.eg/faculty_pharmacy/index.php
Research Year
2019

ENCAPSULATION OF ANTENNAPEDIA (PENETRATIN) PEPTIDE IN A POLYMERIC PLATFORM FOR EFFECTIVE TREATMENT OF
INTRACELLULAR BACTERIA

Research Abstract
Antimicrobial peptides (AMP) and cell-penetrating peptides (CPP) are two classes of peptides that share some structural and physicochemical similarities. Antennapedia or penetratin (ANT) is one of the most known CPPs, that was proven to have antimicrobial activity against certain strains of planktonic bacteria. ANT can enter the cells but has no activity against intracellular bacteria. This is attributable to the inability of the peptide to reach bacteria reside within cellular components as well as low delivery efficiency, due to loss of activity by proteolysis and poor specificity. The aim of this work is to develop a formulation that can effectively reach and attack intracellular bacteria. To achieve this goal, ANT was encapsulated in PLGA platform as nanoparticles with the size range of 500-1000 nm, which allows for selective uptake by macrophages where bacteria mostly reside. ANT was loaded with high loading efficiency (12.7%) inspite of high water solubility. ANT-nanoparticles (ANT-NP) had no cytotoxicity on J774a.1 macrophages and were readily taken up by macrophages as confirmed by fluorescence microscopy. Antibacterial activity of ANT-NP remains to be tested against different intracellular bacteria.
Research Authors
Marwa G. Elnaggar, Hesham M. Tawfeek, Aly A. Abdel-Rahman, Ahmed E. Aboutaleb and Yoon Yeo
Research Department
Research Journal
Bull. Pharm. Sci., Assiut University
Research Publisher
Faculty of Pharmacy, Assiut University
Research Rank
1
Research Vol
Vol. 42
Research Website
http://www.aun.edu.eg/faculty_pharmacy/index.php
Research Year
2019

ENCAPSULATION OF ANTENNAPEDIA (PENETRATIN) PEPTIDE IN A POLYMERIC PLATFORM FOR EFFECTIVE TREATMENT OF
INTRACELLULAR BACTERIA

Research Abstract
Antimicrobial peptides (AMP) and cell-penetrating peptides (CPP) are two classes of peptides that share some structural and physicochemical similarities. Antennapedia or penetratin (ANT) is one of the most known CPPs, that was proven to have antimicrobial activity against certain strains of planktonic bacteria. ANT can enter the cells but has no activity against intracellular bacteria. This is attributable to the inability of the peptide to reach bacteria reside within cellular components as well as low delivery efficiency, due to loss of activity by proteolysis and poor specificity. The aim of this work is to develop a formulation that can effectively reach and attack intracellular bacteria. To achieve this goal, ANT was encapsulated in PLGA platform as nanoparticles with the size range of 500-1000 nm, which allows for selective uptake by macrophages where bacteria mostly reside. ANT was loaded with high loading efficiency (12.7%) inspite of high water solubility. ANT-nanoparticles (ANT-NP) had no cytotoxicity on J774a.1 macrophages and were readily taken up by macrophages as confirmed by fluorescence microscopy. Antibacterial activity of ANT-NP remains to be tested against different intracellular bacteria.
Research Authors
Marwa G. Elnaggar, Hesham M. Tawfeek, Aly A. Abdel-Rahman, Ahmed E. Aboutaleb and Yoon Yeo
Research Department
Research Journal
Bull. Pharm. Sci., Assiut University
Research Publisher
Faculty of Pharmacy, Assiut University
Research Rank
1
Research Vol
Vol. 42
Research Website
http://www.aun.edu.eg/faculty_pharmacy/index.php
Research Year
2019

ENCAPSULATION OF ANTENNAPEDIA (PENETRATIN) PEPTIDE IN A POLYMERIC PLATFORM FOR EFFECTIVE TREATMENT OF
INTRACELLULAR BACTERIA

Research Abstract
Antimicrobial peptides (AMP) and cell-penetrating peptides (CPP) are two classes of peptides that share some structural and physicochemical similarities. Antennapedia or penetratin (ANT) is one of the most known CPPs, that was proven to have antimicrobial activity against certain strains of planktonic bacteria. ANT can enter the cells but has no activity against intracellular bacteria. This is attributable to the inability of the peptide to reach bacteria reside within cellular components as well as low delivery efficiency, due to loss of activity by proteolysis and poor specificity. The aim of this work is to develop a formulation that can effectively reach and attack intracellular bacteria. To achieve this goal, ANT was encapsulated in PLGA platform as nanoparticles with the size range of 500-1000 nm, which allows for selective uptake by macrophages where bacteria mostly reside. ANT was loaded with high loading efficiency (12.7%) inspite of high water solubility. ANT-nanoparticles (ANT-NP) had no cytotoxicity on J774a.1 macrophages and were readily taken up by macrophages as confirmed by fluorescence microscopy. Antibacterial activity of ANT-NP remains to be tested against different intracellular bacteria.
Research Authors
Marwa G. Elnaggar, Hesham M. Tawfeek, Aly A. Abdel-Rahman, Ahmed E. Aboutaleb and Yoon Yeo
Research Department
Research Journal
Bull. Pharm. Sci., Assiut University
Research Publisher
Faculty of Pharmacy, Assiut University
Research Rank
1
Research Vol
Vol. 42
Research Website
http://www.aun.edu.eg/faculty_pharmacy/index.php
Research Year
2019
Subscribe to